Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner

Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.-- in association with the Medco Research Institute™ -- and Mayo Clinic announced. Results of the first nationwide prospective study examining outcomes when incorporating genetic testing into the management of warfarin as part of the usual care of patients were presented today at the American College of Cardiology's 59th annual scientific session and will be published in the Journal of the American College of Cardiology.

...

Want to see the full article?

• Purchase this article for only $3.00